SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.80+1.2%11:25 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DMB who wrote (22810)6/29/1998 1:11:00 AM
From: Robert L. Ray  Read Replies (2) of 32384
 
>>>As a physician, I am curious what drugs, in your perception, have been kept off the market to the detriment of the public?<<<

The question wasn't directed at me but I know of one for sure. Duramed (DRMD) last year had their generic version of Premarin turned down in what has to be one of the most outragous actions the FDA has ever taken. The FDA laid out the ground rules for approval of the DRMD drug. DRMD met all the requirements. And in the 11th hour AHP apparently lobbied the FDA and said hey wait a minute... Premarin has some ingredients in it that the DRMD drug doesn't. That was true. These *ingredients* are actually inactive contaminants in Premarin. Never the less this gambit by AHP worked. It's of course widely suspected that the whole fiasco was politically motivated. (Especially by DRMD and ex-DRMD shareholders:) At any rate this is one example where the FDA has royally screwed up to the financial detriment of the American public since the public would have saved millions with generic Premarin.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext